Richard Nolan Townsend
Chief Executive Officer at Lexeo Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Lexeo Therapeutics Inc., 2 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Lexeo Therapeutics Inc. June 25, 202698.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 18, 2026 | Lexeo Therapeutics Inc. | Open-market sale | −3,345 | $4.95 | $16,562 |
| Jul 1, 2026 | Lexeo Therapeutics Inc. | Open-market sale | −25,947 | $4.48 | $116,243 |
| Jun 29, 2026 | Lexeo Therapeutics Inc. | Grant or award | +67,000 | — | — |
| May 18, 2026 | Lexeo Therapeutics Inc. | Open-market sale | −3,342 | $5.06 | $16,911 |
| Apr 6, 2026 | Lexeo Therapeutics Inc. | Open-market sale | −55,000 | $5.69 | $312,950 |
| Mar 13, 2026 | Lexeo Therapeutics Inc. | Grant or award | +2,623 | $2.64 | $6,925 |
| Feb 18, 2026 | Lexeo Therapeutics Inc. | Open-market sale | −10,173 | $6.38 | $64,904 |
| Feb 4, 2026 | Lexeo Therapeutics Inc. | Grant or award | +161,665 | — | — |
| Nov 18, 2025 | Lexeo Therapeutics Inc. | Open-market sale | −1,127 | $9.27 | $10,447 |
| Oct 17, 2025 | Lexeo Therapeutics Inc. | Open-market sale | −12,985 | $8.94 | $116,086 |
| Oct 17, 2025 | Lexeo Therapeutics Inc. | Open-market sale | −148 | $9.56 | $1,415 |
| Oct 15, 2025 | Lexeo Therapeutics Inc. | Grant or award | +33,000 | — | — |
| Sep 12, 2025 | Lexeo Therapeutics Inc. | Grant or award | +2,193 | $2.64 | $5,790 |
| Aug 18, 2025 | Lexeo Therapeutics Inc. | Open-market sale | −2,735 | $4.67 | $12,772 |
| May 16, 2025 | Lexeo Therapeutics Inc. | Open-market sale | −1,074 | $2.77 | $2,975 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.